Home › Core › ISCC-IDs › 28CrZor79qHrf

View ISCC-ID

Core Data

28CrZor79qHrf
ISCC-ID - digital asset identifier
CCLTvHe8SYZz3-CTKipPnee43NX-CDhft88Cee2P5-CRCNQgzxYG97m
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

longterm safety of aromatase inhibitors in the treatment of breast cancer

Ledger Reference

coblo
Source Ledger/Blockchain
12345974
N-th ISCC Decleration on source ledger
0fc9559d4fe45eaa7e5c5971664240b191f6ce07a041d5a7b75f10d544dde4de
Hash of block that includes the ISCC-DECLARATION
bda217e62e27a652c3bf52a3f0fb106167f24a28418d4157447e1c0902942db7
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Long-term safety of aromatase inhibitors in the treatment of breast cancer", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "J M Nabholtz", "@type": "Person"}], "license": "cc-by-nc", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc2503653?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "Informa UK Limited", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.2147/tcrm.s1566", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCLTvHe8SYZz3-CTKipPnee43NX-CDhft88Cee2P5-CRCNQgzxYG97m", "propertyID": "ISCC"}], "datePublished": "2008-02-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close